Rehearing DENIED.

DISTRIBUTED for Conference of 1/6/2023.

Petition for Rehearing filed.

Petition DENIED.

DISTRIBUTED for Conference of 11/4/2022.

DISTRIBUTED for Conference of 10/28/2022.

DISTRIBUTED for Conference of 10/14/2022.

DISTRIBUTED for Conference of 10/7/2022.

Reply of petitioners Juno Therapeutics, Inc., et al. filed. (Distributed)

DISTRIBUTED for Conference of 9/28/2022.

Brief of respondent Kite Pharma, Inc. in opposition filed.

Motion to extend the time to file a response is granted and the time is extended to and including August 24, 2022.

Motion to extend the time to file a response from July 15, 2022 to August 24, 2022, submitted to The Clerk.

Petition for a writ of certiorari filed. (Response due July 15, 2022)

Application (21A461) granted by The Chief Justice extending the time to file until June 13, 2022.

Application (21A461) to extend the time to file a petition for a writ of certiorari from April 14, 2022 to June 13, 2022, submitted to The Chief Justice.

Juno Therapeutics, Inc., et al., Petitioner, represented by Gregory Andrew Castanias

Kite Pharma, Inc., Respondent, represented by E. Joshua Rosenkranz

Amgen Inc., Association of University Technology Managers (AUTM), Instil Bio, Inc., Corning Incorporated, Bavarian Nordic A/S, and GlaxoSmithKline plc, Amicus Curiae, represented by Jeffrey Alan Lamken

City of Hope, Amicus Curiae, represented by Daralyn Jeannine Durie

Mark D. Janis and Timothy R. Holbrook, Amicus Curiae, represented by Timothy R. Holbrook

REGENXBIO Inc., Amicus Curiae, represented by Matthew James Dowd

St. Jude Children’s Research Hospital, Inc., Albert Einstein College of Medicine, the University of Texas MD Anderson Cancer Center, and Other Academic Research Institutions, Amicus Curiae, represented by Vanessa Y. Yen